Is p53 Immunohistochemistry a Reliable Indicator of TP53 mutation? An NGS-based assessment in lung adenocarcinoma
Gizem Teoman, Zeynep Sagnak Yilmaz, Safak Ersoz, Sevdegul Aydin Mungan · 2026
Read Is p53 Immunohistochemistry a Reliable Indicator of TP53 mutation? An NGS-based assessment in lung adenocarcinoma by Gizem Teoman, Zeynep Sagnak Yilmaz, Safak Ersoz, Sevdegul Aydin Mungan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13263588.txt.
Description
A cheap stain test is often used as a stand-in for gene mutation in a major cancer gene, and a study checked how honest that stand-in is in lung tumors. Gizem Teoman and co-authors carried out the check in this 2026 paper. They reviewed one hundred and sixty-six lung adenocarcinoma cases diagnosed between twenty twenty and twenty twenty-five.
Stain patterns were sorted into over-expression, absent, and normal, while gene sequencing sorted the actual mutations by type. The team computed how often the stain called the mutation status correctly. Labs in low-resource settings rely on the stain because sequencing is costly. Knowing its error rates tells pathologists when the cheap answer can be trusted and when sequencing is mandatory.
Catalog record
| CREATOR | Gizem Teoman, Zeynep Sagnak Yilmaz, Safak Ersoz, Sevdegul Aydin Mungan |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 24 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |